Washington, USA
+919405476170
+919405476170

Buy Gefitinib 250 mg Tablets from Oncology Supplier New York

Gefitinib 250 mg New York • Gefitinib Tablets New York • Gefitinat 250 mg • Oncology Medicine Supplier New York • Gefitinib Exporter from India
Ernest Oncology supports professional B2B enquiries for Gefitinib 250 mg Tablets from pharmaceutical distributors, licensed importers, wholesalers and healthcare procurement businesses serving New York City, New York.

Gefitinib 250 mg Product Overview

Gefitinib is a prescription targeted cancer medicine belonging to the  EGFR tyrosine kinase inhibitor (TKI) class. It is used for certain patients with non-small cell lung cancer (NSCLC) whose tumors have specific EGFR mutations, according to approved prescribing criteria.
Product Specification
Generic Name       Gefitinib
Strength                   250 mg
Dosage Form       Tablets
Therapeutic Segment Oncology
Medicine Class       EGFR Tyrosine Kinase Inhibitor
Target Market       New York City, New York
Supply Type            Wholesale / Institutional/ B2B

Oncology Sourcing for New York

Professional buyers may contact Ernest Oncology regarding available Gefitinib brands, pack configurations, bulk requirements, batch details, commercial quotations and available documentation.
Gefitinib is a prescription oncology medicine and should only be used under appropriate specialist medical supervision.
Gefitinib supplier New York, Gefitinib 250 mg wholesale, lung cancer medicine supplier New York, targeted therapy supplier USA, oncology pharmaceutical supplier New York.

Bulk Gefitinib Requirements for New York

Businesses looking for Gefitinib 250 mg wholesale or bulk supply in New York should provide the required quantity, preferred packaging and destination when submitting an enquiry.

This enables Ernest Oncology to review the requirement and provide relevant commercial and product information.

Frequently Asked Questions (FAQs)

1. What is Gefitinib 250 mg used for?
Gefitinib is a prescription targeted therapy used for certain patients with EGFR mutation-positive non-small cell lung cancer (NSCLC). Patient eligibility should be determined by an oncology specialist.

2. Is Gefitinib available as a 250 mg tablet?
Yes. Gefitinib is available in a 250 mg oral tablet formulation, subject to brand and market availability.

3. Can B2B buyers source Gefitinib 250 mg Tablets for New York?
Ernest Oncology supports commercial enquiries from eligible pharmaceutical distributors, licensed importers, wholesalers and institutional healthcare procurement organisations serving New York.

4. Can wholesalers enquire about Gefitinib 250 mg in bulk?
Yes. Eligible professional buyers can enquire about Gefitinib 250 mg bulk and wholesale supply, including available pack sizes, quantities and commercial terms.

5. How does Gefitinib work?
Gefitinib is an EGFR tyrosine kinase inhibitor. It blocks specific EGFR signalling involved in the growth of certain cancer cells.

 Contact Ernest Oncology 

Official Websites

🌐 www.oncologymedicinesupplier.com
WhatsApp
📱 +91 93599 02383
Chat with Us on WhatsApp
💬 https://wa.me/919359902383

 2026-08-12T11:44:25

Keywords